Accelerate diagnostics announces agreements to exchange approximately $51 million in principal amount of its 2.50% convertible senior notes due 2023 for common stock

Tucson, ariz., sept. 23, 2021 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) today announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 2.50% convertible senior notes due 2023 (the "notes").

AXDX Ratings Summary

AXDX Quant Ranking